Burden of Adults Hospitalized With Group B Streptococcal Infection

Background. The burden of noninvasive group B Streptococcus (GBS) infections in adults is unknown. We determined population-based rates of hospitalization where invasive or noninvasive GBS infections were identified among US adults in a defined catchment area. Methods. We identified adults with clinical and laboratory-confirmed evidence of GBS infection from January 2014 through December 2016 from 6 hospitals in Louisville, Kentucky. Invasive disease was defined as GBS isolated from a normally sterile site. Results. Among 1076 adults with GBS infection, the median age was 52 years, 51% were male, and 89% had >= 1 chronic medical condition. The most prevalent infection sites were skin and soft tissue (39%), urinary tract (23%), bone and joint (16%), and blood-stream (11%). Forty percent of infections were polymicrobial. The annual incidence of GBS-associated hospitalization was 73 per 100 000 adults and 68 and 100 per 100 000 for patients aged 18-64 and >= 65 years, respectively. For every invasive GBS infection, 3.7 noninvasive infections occurred. Conclusions. Our population-based study outlines the full burden of GBS- associated hospitalization in adults and found incidence rates comparable to those of pneumococcal disease, where vaccines are recommended. Noninvasive disease was 3-4 times more common than invasive disease, suggesting that the GBS burden among adults is considerably greater than previously recognized.

Automated summary

A population-based study in adults found the annual incidence of GBS-associated hospitalization to be 73 per 100,000 adults, with noninvasive GBS infections occurring 3.7 times more often than invasive infections. This suggests that the burden of GBS among adults is greater than previously recognized.